查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1630961

全球蛋白酶 K 市场：市场规模、份额和趋势分析（按形式、治疗领域、应用、最终用途、地区和细分市场，2025-2030 年）

Proteinase K Market Size, Share & Trends Analysis Report By Form (Powder, Liquid), By Therapeutic Area (Infectious Diseases, Neurology, Oncology, Cardiology), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

蛋白酶 K 市场的成长与趋势：

预计到 2030 年全球蛋白酶 K 市场规模将达到 78.4 亿美元，2025 年至 2030 年的复合年增长率为 8.5%。市场的成长得益于分子诊断技术和相关体外诊断酶的广泛应用。蛋白酶K可用作PCR和NGS的辅助剂。基因表现表现谱和 qPCR 标靶面板仍然是病理实验室中 NGS 定序最常见的应用。

NGS 在个人化医疗中的日益广泛的应用以及各种临床开发的治疗方法可能会有利于蛋白酶 K 市场。基因表现表现谱和 qPCR 标靶面板是病理实验室中 NGS 定序最常见的用途。此外，NGS定序成本的下降也正在扩大NGS技术的使用范围。因此，对NGS诊断技术不断增长的需求预计将推动市场成长。

此外，细胞分离程序的采用率不断提高也是推动市场成长的主要因素之一。公司开始建立永续技术以在市场上取得竞争优势。例如，2022年4月，Levitas Bio宣布了其现有细胞分离平台的下一代产品。新版本预计将帮助研究人员将实验规模扩大 16 倍，每次运行可处理约 4,000 万个细胞。

此外，基于 POC 的诊断的使用在世界范围内正在显着增加。旨在识别感染疾病症状和如何预防传染病的公众意识宣传活动在控制疾病传播方面发挥重要作用。因此，患者兴趣的增加导致对 POC 的需求增加。例如，2020 年 5 月发表了一项使用特定高灵敏度酶报告基因解锁 (SHERLOCK) 诊断方法进行 COVID-19 POC 测试的研究。研究人员使用了 Lucigen 的 QuickExtract，其中含有蛋白酶 K。因此，对 POC 诊断的不断增长的需求以及蛋白酶 K 在 POC 诊断测试中的效用预计将推动市场成长。

此外，蛋白酶K在分子生物学和其他领域的不断扩大的应用预计将在不久的将来创造丰厚的利润机会。蛋白酶K用于食品和饮料行业以维持品质标准。食品製造商努力保持生产中使用的原材料的品质。此外，蛋白酶K用于从加工食品中提取 DNA 过程中的细胞裂解。这种酵素也可广泛应用于多种生物鑑定。因此，预计蛋白酶 K 的此类应用将在预测期内推动市场发展。

蛋白酶 K 市场概览

  • 从形式来看，粉末部分在 2024 年占据主导地位。粉末的优点包括保存期限更长、运输成本更低、稳定性更高。因此，这些优势有望增加粉末的采用。
  • 根据治疗领域，感染疾病领域在 2024 年占据最大份额。随着中低收入国家感染疾病的盛行率不断上升，快速分子检测中蛋白酶K的存在有望促进在资源匮乏的环境下易于操作的产品的开发。这正在加速市场的成长。
  • 按应用划分，基因组 DNA 和 RNA 分离和精製领域在 2024 年占据最大份额。随着癌症和罕见疾病个人化治疗的需求日益增长，对DNA和RNA分离的需求也不断增加，类似的趋势也将在市场上反映出来。
  • 根据最终用途，生技公司在 2024 年占据了主要收益占有率。这是因为生物技术公司越来越多地应用原位杂合反应(ISH) 技术来支持临床和临床前研究。
  • 由于定序技术的应用日益广泛，加上政府推出各种倡议推动基因组学研究，预计亚太地区未来将显着成长。

目录

第一章 分析方法及范围

第 2 章执行摘要

3. 蛋白酶 K 市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 蛋白酶 K 市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL 分析

第 4 章蛋白酶 K 市场：配方特定估计与趋势分析

  • 按形状分類的市场占有率（2024 年和 2030 年）
  • 细分仪表板
  • 全球蛋白酶 K 市场展望（按形式）
  • 市场规模预测及形状趋势分析（2018-2030）
    • 粉末
    • 液体

5. 蛋白酶 K 市场：按治疗领域的估计和趋势分析

  • 按治疗领域分類的市场占有率（2024 年和 2030 年）
  • 细分仪表板
  • 全球蛋白酶 K 市场前景（按治疗领域）
  • 依治疗领域分類的市场规模预测及趋势分析（2018-2030）
    • 感染疾病
    • 糖尿病
    • 肿瘤学
    • 心臟病学
    • 肾臟科
    • 自体免疫疾病
    • 神经病学
    • 其他的

第 6 章蛋白酶 K 市场：按应用进行的估计和趋势分析

  • 按应用分類的市场占有率（2024 年和 2030 年）
  • 细分仪表板
  • 全球蛋白酶 K 市场应用展望
  • 按应用分類的市场规模预测和趋势分析（2018-2030 年）
    • 基因组 DNA 和 RNA 的分离与精製
    • 原位杂合反应
    • 粒线体的分离

7. 蛋白酶 K 市场：按最终用途的估计和趋势分析

  • 按最终用途分類的市场占有率（2024 年和 2030 年）
  • 细分仪表板
  • 全球蛋白酶 K 市场前景（按最终用途）
  • 按最终用途分類的市场规模预测和趋势分析（2018-2030 年）
    • CMO（委外研发机构）
    • 学术机构
    • 生技公司
    • 诊断实验室

第 8 章蛋白酶 K 市场：区域估计与趋势分析

  • 按形状分類的市场占有率（2024 年和 2030 年）
  • 区域市场仪表板
  • 全球市场概况：按地区
  • 市场规模预测及趋势分析（2018-2030年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商概况
    • 主要企业的市场占有率分析（2024 年）
    • Merck KGaA
    • QIAGEN
    • Thermo Fisher Scientific, Inc
    • F. Hoffmann-La Roche Ltd
    • Abcam plc
    • Agilent Technologies, Inc
    • Biocatalysts
    • Minerva Biolabs GmbH
    • Promega Corporation
    • Takara Bio Inc
    • New England Biolabs
    • MP Biomedicals
Product Code: GVR-4-68039-172-8

Proteinase K Market Growth & Trends:

The global proteinase K market size is expected to reach USD 7.84 billion in 2030 and is expected to grow at a CAGR of 8.5% from 2025 to 2030. The market growth is fueled by a broad range of applications in molecular diagnostic techniques and their associated enzymes for IVD. Proteinase K can be utilized as a supplement in PCR and NGS. Increasing applications of NGS in personalized medicine along with various clinically developed therapies are likely to favor the market for proteinase K. Gene expression profiling and targeted panels via qPCR remain the two most frequent uses for NGS sequences in a pathology lab. In addition, a decline in the price of NGS sequencing has expanded the use of NSC technologies. Therefore, the growing demand for NGS diagnostic techniques is expected to boost the market growth.

In addition, the rising adoption of cell separation procedures is one of the major factors contributing to the market growth. Companies have initiated building sustainable technologies to gain a competitive edge in the market. For instance, in April 2022, Levitas Bio introduced the next generation of its existing platform for cell separation. The new version is expected to assist researchers in scaling their experiments up to 16X and process around 40 million cells per run.

Moreover, the usage of POC-based diagnostics is increasing significantly globally. Public awareness campaigns aimed at identifying the symptoms of infectious diseases and ways to prevent them play an important role in controlling disease transmission. Thus, increased patient attention has led to a rise in demand for POC. For instance, in May 2020, a study on POC testing for COVID-19 through Specific High Sensitivity Enzymatic Reporter UnLOCKing (SHERLOCK) diagnostics was published. The researchers used QuickExtract by Lucigen, which contains Proteinase K. Thus, the growing demand for POC diagnostics and the utility of proteinase K in POC diagnostic tests are expected to fuel market growth.

Furthermore, growing applications of proteinase K in molecular biology and other fields are expected to create lucrative opportunities in the near future. Proteinase K is used in the food and beverage industry to maintain quality standards. Food manufacturers work to maintain the quality of raw materials used for manufacturing. In addition, proteinase K is used for cell lysis during DNA extraction from processed foods. The enzyme also finds application in a wide range of molecular biology assays. Hence, such applications of proteinase K are anticipated to drive the market during the forecast period.

Proteinase K Market Report Highlights:

  • By form, the powder segment accounted for a dominant share in 2024. Advantages of powder form include long shelf-life, inexpensive shipment, and high stability. Thus, such advantages are expected to increase the adoption of powder
  • By therapeutic area, the infectious diseases segment captured the largest share in 2024. Presence of proteinase K in the rapid molecule testing along with increasing incidence of infectious diseases in low- to mid-income countries is anticipated to encourage players to develop products that are easy to operate in a low-resource setting. This is, in turn, accelerating the market growth
  • By application, the isolation and purification of genomic DNA and RNA segment held the largest share in 2024. With the emerging need for personalized treatment in cancer and rare diseases, the demand for DNA or RNA isolation is anticipated to witness upward trends and similar trends will be reflected in the market
  • By end-use, biotechnology companies held a leading revenue share in 2024. This is due to an increase in the application of In Situ Hybridization (ISH) techniques to support clinical and preclinical studies for biotechnology companies
  • Asia Pacific is projected to grow considerably in the future owing to increasing applications of sequencing technology, coupled with various government initiatives to promote genomics research.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Form
    • 1.2.2. Therapeutic area
    • 1.2.3. End use
    • 1.2.4. Application
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Form outlook
    • 2.2.2. Therapeutic area outlook
    • 2.2.3. End use outlook
    • 2.2.4. Application outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Proteinase K Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growth in Molecular Diagnostics
      • 3.2.1.2. Rise in Genomic Research
      • 3.2.1.3. Increasing Adoption in Forensic Science
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Availability of Alternative Enzymes
  • 3.3. Proteinase K Market Analysis Tools
    • 3.3.1. Industry Analysis -Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Proteinase K Market: Form Estimates & Trend Analysis

  • 4.1. Form Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Proteinase K Market by Form Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Powder
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 4.4.2. Liquid
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Proteinase K Market: Therapeutic Area Estimates & Trend Analysis

  • 5.1. Therapeutic Area Market Share, 2024 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Proteinase K Market by Therapeutic Area Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Infectious Diseases
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 5.4.2. Diabetes
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Oncology
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Cardiology
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Nephrology
      • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.6. Autoimmune Diseases
      • 5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.7. Neurology
      • 5.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.8. Others
      • 5.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Proteinase K Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2024 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Proteinase K Market by Application Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Isolation and Purification of Genomic DNA & RNA
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 6.4.2. In Situ Hybridization
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Mitochondria Isolation
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Proteinase K Market: End Use Estimates & Trend Analysis

  • 7.1. End Use Market Share, 2024 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Proteinase K Market by End Use Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Contract Research Organization
      • 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 7.4.2. Academic Institutes
      • 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Biotechnology Companies
      • 7.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Diagnostic Laboratories
      • 7.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Proteinase K Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. France
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. Italy
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework/ reimbursement structure
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Spain
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework/ reimbursement structure
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Norway
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework/ reimbursement structure
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework/ reimbursement structure
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.8. Denmark
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework/ reimbursement structure
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Japan
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Australia
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework/ reimbursement structure
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.6. Thailand
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework/ reimbursement structure
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework/ reimbursement structure
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. Argentina
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework/ reimbursement structure
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9. MEA
    • 8.9.1. South Africa
      • 8.9.1.1. Key country dynamics
      • 8.9.1.2. Regulatory framework/ reimbursement structure
      • 8.9.1.3. Competitive scenario
      • 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework/ reimbursement structure
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.3. UAE
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework/ reimbursement structure
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.4. Kuwait
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework/ reimbursement structure
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. Key company market share analysis, 2024
    • 9.3.2. Merck KGaA
      • 9.3.2.1. Company overview
      • 9.3.2.2. Financial performance
      • 9.3.2.3. Product benchmarking
      • 9.3.2.4. Strategic initiatives
    • 9.3.3. QIAGEN
      • 9.3.3.1. Company overview
      • 9.3.3.2. Financial performance
      • 9.3.3.3. Product benchmarking
      • 9.3.3.4. Strategic initiatives
    • 9.3.4. Thermo Fisher Scientific, Inc
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. F. Hoffmann-La Roche Ltd
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Abcam plc
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Agilent Technologies, Inc
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Biocatalysts
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Minerva Biolabs GmbH
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Promega Corporation
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Takara Bio Inc
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. New England Biolabs
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives
    • 9.3.13. MP Biomedicals
      • 9.3.13.1. Company overview
      • 9.3.13.2. Financial performance
      • 9.3.13.3. Product benchmarking
      • 9.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 4 Global Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 5 Global Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 6 Global Proteinase K Market, by End use, 2018 - 2030 (USD Million)
  • Table 7 Global Proteinase K Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Proteinase K Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 10 North America Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 11 North America Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 12 North America Proteinase K Market, by End use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 14 U.S. Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 15 U.S. Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 16 U.S. Proteinase K Market, End use, 2018 - 2030 (USD Million)
  • Table 17 Canada Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 18 Canada Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 19 Canada Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 20 Canada Proteinase K Market, End use, 2018 - 2030 (USD Million)
  • Table 21 Mexico Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 22 Mexico Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 23 Mexico Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 Mexico Proteinase K Market, End use, 2018 - 2030 (USD Million)
  • Table 25 Europe Proteinase K Market, by Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 27 Europe Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 28 Europe Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 29 Europe Proteinase K Market, End use, 2018 - 2030 (USD Million)
  • Table 30 Germany Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 31 Germany Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 32 Germany Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 33 Germany Proteinase K Market, End use, 2018 - 2030 (USD Million)
  • Table 34 UK Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 35 UK Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 36 UK Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 37 UK Proteinase K Market, End use, 2018 - 2030 (USD Million)
  • Table 38 France Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 39 France Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 40 France Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 41 France Proteinase K Market, End use, 2018 - 2030 (USD Million)
  • Table 42 Italy Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 43 Italy Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 44 Italy Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 45 Italy Proteinase K Market, End use, 2018 - 2030 (USD Million)
  • Table 46 Spain Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 47 Spain Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 48 Spain Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 49 Spain Proteinase K Market, End use, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Proteinase K Market, by Country, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific Proteinase K Market, End use, 2018 - 2030 (USD Million)
  • Table 55 China Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 56 China Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 57 China Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 58 China Proteinase K Market, End use, 2018 - 2030 (USD Million)
  • Table 59 Japan Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 60 Japan Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 61 Japan Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 62 Japan Proteinase K Market, End use, 2018 - 2030 (USD Million)
  • Table 63 India Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 64 India Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 65 India Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 66 India Proteinase K Market, End use, 2018 - 2030 (USD Million)
  • Table 67 Singapore Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 68 Singapore Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 69 Singapore Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 70 Singapore Proteinase K Market, End use, 2018 - 2030 (USD Million)
  • Table 71 Australia Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 72 Australia Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 73 Australia Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 74 Australia Proteinase K Market, End use, 2018 - 2030 (USD Million)
  • Table 75 Latin America Proteinase K Market, by Country, 2018 - 2030 (USD Million)
  • Table 76 Latin America Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 77 Latin America Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 78 Latin America Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 79 Latin America Proteinase K Market, End use, 2018 - 2030 (USD Million)
  • Table 80 Brazil Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 81 Brazil Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 82 Brazil Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 83 Brazil Proteinase K Market, End use, 2018 - 2030 (USD Million)
  • Table 84 Argentina Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 85 Argentina Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 86 Argentina Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 87 Argentina Proteinase K Market, End use, 2018 - 2030 (USD Million)
  • Table 88 Middle East & Africa Proteinase K Market, by Country, 2018 - 2030 (USD Million)
  • Table 89 Middle East & Africa Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 90 Middle East & Africa Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 91 Middle East & Africa Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 92 Middle East & Africa Proteinase K Market, End use, 2018 - 2030 (USD Million)
  • Table 93 South Africa Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 94 South Africa Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 95 South Africa Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 96 South Africa Proteinase K Market, End use, 2018 - 2030 (USD Million)
  • Table 97 Saudi Arabia Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 98 Saudi Arabia Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 99 Saudi Arabia Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 100 Saudi Arabia Proteinase K Market, End use, 2018 - 2030 (USD Million)
  • Table 101 UAE Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 102 UAE Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 103 UAE Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 104 UAE Proteinase K Market, End use, 2018 - 2030 (USD Million)
  • Table 105 Kuwait Proteinase K Market, by Form, 2018 - 2030 (USD Million)
  • Table 106 Kuwait Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 107 Kuwait Proteinase K Market, by Application, 2018 - 2030 (USD Million)
  • Table 108 Kuwait Proteinase K Market, End use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Proteinase K Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Proteinase K Market: Form Movement Analysis
  • Fig. 16 Global Proteinase K Market, for Powder, 2018 - 2030 (USD Million)
  • Fig. 17 Global Proteinase K Market, for Liquid, 2018 - 2030 (USD Million)
  • Fig. 18 Global Proteinase K Market: Therapeutic Area Movement Analysis
  • Fig. 19 Global Proteinase K Market, for Infectious diseases, 2018 - 2030 (USD Million)
  • Fig. 20 Global Proteinase K Market, for Diabetes, 2018 - 2030 (USD Million)
  • Fig. 21 Global Proteinase K Market, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 22 Global Proteinase K Market, for Cardiology, 2018 - 2030 (USD Million)
  • Fig. 23 Global Proteinase K Market, for Nephrology, 2018 - 2030 (USD Million)
  • Fig. 24 Global Proteinase K Market, for Autoimmune diseases, 2018 - 2030 (USD Million)
  • Fig. 25 Global Proteinase K Market, for Neurology, 2018 - 2030 (USD Million)
  • Fig. 26 Global Proteinase K Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 27 Global Proteinase K Market: Application Movement Analysis
  • Fig. 28 Global Proteinase K Market, for Isolation and Purification of Genomic DNA & RNA, 2018 - 2030 (USD Million)
  • Fig. 29 Global Proteinase K Market, for In Situ Hybridization, 2018 - 2030 (USD Million)
  • Fig. 30 Global Proteinase K Market, for Mitochondria isolation, 2018 - 2030 (USD Million)
  • Fig. 31 Global Proteinase K Market: End use Movement Analysis
  • Fig. 32 Global Proteinase K Market, for Contract Research Organization, 2018 - 2030 (USD Million)
  • Fig. 33 Global Proteinase K Market, for Academic Institutes, 2018 - 2030 (USD Million)
  • Fig. 34 Global Proteinase K Market, for Biotechnology Companies, 2018 - 2030 (USD Million)
  • Fig. 35 Global Proteinase K Market, for Diagnostic Laboratories, 2018 - 2030 (USD Million)
  • Fig. 36 Regional Marketplace: Key Takeaways
  • Fig. 37 Regional Outlook, 2024 & 2030
  • Fig. 38 Global Biochips Market: Region Movement Analysis
  • Fig. 39 North America Proteinase K Market, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. Proteinase K Market, 2018 - 2030 (USD Million)
  • Fig. 41 Canada Proteinase K Market, 2018 - 2030 (USD Million)
  • Fig. 42 Mexico Proteinase K Market, 2018 - 2030 (USD Million)
  • Fig. 43 Europe Proteinase K Market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany Proteinase K Market, 2018 - 2030 (USD Million)
  • Fig. 45 UK Proteinase K Market, 2018 - 2030 (USD Million)
  • Fig. 46 France Proteinase K Market, 2018 - 2030 (USD Million)
  • Fig. 47 Italy Proteinase K Market, 2018 - 2030 (USD Million)
  • Fig. 48 Spain Proteinase K Market, 2018 - 2030 (USD Million)
  • Fig. 49 Asia Pacific Proteinase K Market, 2018 - 2030 (USD Million)
  • Fig. 50 Japan Proteinase K Market, 2018 - 2030 (USD Million)
  • Fig. 51 China Proteinase K Market, 2018 - 2030 (USD Million)
  • Fig. 52 India Proteinase K Market, 2018 - 2030 (USD Million)
  • Fig. 53 Singapore Proteinase K Market, 2018 - 2030 (USD Million)
  • Fig. 54 Australia Proteinase K Market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America Proteinase K Market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil Proteinase K Market, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina Proteinase K Market, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East and Africa Proteinase K Market, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa Proteinase K Market, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia Proteinase K Market, 2018 - 2030 (USD Million)
  • Fig. 61 UAE Proteinase K Market, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait Proteinase K Market, 2018 - 2030 (USD Million)